help button home button Am J Pathol PCR Enhanced. PCRboost from Biomatrica
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van der Kraan, P. M.
Right arrow Articles by van den Berg, W. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van der Kraan, P. M.
Right arrow Articles by van den Berg, W. B.

American Journal of Pathology, Vol 135, 1001-1014, Copyright © 1989 by American Society for Investigative Pathology


REGULAR ARTICLES

Development of osteoarthritic lesions in mice by "metabolic" and "mechanical" alterations in the knee joints

PM van der Kraan, EL Vitters, LB van de Putte and WB van den Berg
Department of Rheumatology, Academic Hospital St. Radboud, Nijmegen, The Netherlands.

Male, 10-week-old C57B1 10 mice received a single intraarticular injection in the knee joints with papain, iodoacetate, or collagenase. This led to osteoarthritic lesions, such as matrix depletion, chondrocyte proliferation, and osteophyte formation, in the injected knee joints within several weeks. After injection of iodoacetate and papain, the main osteoarthritic alterations were localized in the femoropatellar joint, whereas injection of collagenase led to marked osteoarthritic lesions in the femorotibial joint. The mechanism of induction of these alterations appears to differ for iodoacetate and papain on one site and collagenase on the other site. Data are presented that collagenase injection, by way of damaging ligaments and tendons, destabilizes the knee joint eventually leading to osteoarthritic alterations. In contrast, injection of papain or iodoacetate directly interferes with cartilage metabolism resulting in osteoarthritic changes.


This article has been cited by other articles:


Home page
Ann Rheum DisHome page
C Boileau, F Poirier, J-P Pelletier, M Guevremont, N Duval, J Martel-Pelletier, and P Reboul
Intracellular localisation of galectin-3 has a protective role in chondrocyte survival
Ann Rheum Dis, February 1, 2008; 67(2): 175 - 181.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
E N Blaney Davidson, E L Vitters, P M van der Kraan, and W B van den Berg
Expression of transforming growth factor-{beta} (TGF{beta}) and the TGF{beta} signalling molecule SMAD-2P in spontaneous and instability-induced osteoarthritis: role in cartilage degradation, chondrogenesis and osteophyte formation
Ann Rheum Dis, November 1, 2006; 65(11): 1414 - 1421.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
R. E. Guzman, M. G. Evans, S. Bove, B. Morenko, and K. Kilgore
Mono-Iodoacetate-Induced Histologic Changes in Subchondral Bone and Articular Cartilage of Rat Femorotibial Joints: An Animal Model of Osteoarthritis
Toxicol Pathol, October 1, 2003; 31(6): 619 - 624.
[Abstract] [PDF]


Home page
J. Immunol.Home page
A. Scharstuhl, H. L. Glansbeek, H. M. van Beuningen, E. L. Vitters, P. M. van der Kraan, and W. B. van den Berg
Inhibition of Endogenous TGF-{beta} During Experimental Osteoarthritis Prevents Osteophyte Formation and Impairs Cartilage Repair
J. Immunol., July 1, 2002; 169(1): 507 - 514.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1989 by the American Society for Investigative Pathology.